No. of patients | 65 |
Indication 18F-fluorocholine PET/CT | |
Primary staging | 21 |
Biochemical relapse | 34 |
Therapy follow-up | 8 |
Other | 2 |
Mean age (y) | 62 (range, 52–84) |
Mean PSA at scanning (ng/mL) | 56 (range, 0.1–1,481) |
Gleason score | |
6 | 4 |
7 | 16 |
8 | 18 |
9 | 10 |
Unknown | 17 |
cT stage at diagnosis | |
x | 19 |
1 | 5 |
2 | 15 |
3a | 18 |
3b | 7 |
4 | 1 |
cN stage at diagnosis | |
x | 42 |
0 | 17 |
1 | 6 |
Previous therapy | |
Prostatectomy | 16 |
External radiation therapy | 19 |
Brachytherapy | 1 |
Previous salvage therapy | |
External radiotherapy | 7 |
High-intensity focused ultrasound | 4 |
Patients on hormone therapy at scanning | |
Yes | 7 |
No | 58 |